| |
|
| Medical Writing
Services cooperates closely with the
client’s pre-clinical and clinical team members to ensure investigator
brochures fulfil the special requirements of this widely read document.
When writing this document, we consider completeness,
accuracy, and high readability to be essential and we give full attention
to the client’s demands for internal and external review and
approval procedures. |
 |
|
 |
This regulatory document is an important
summary of a new drug and should present an up-to-date account of
the results of pre-clinical studies and clinical trials in healthy
volunteers and patients. It should be well used and appreciated not
only by the trial investigator but by all those involved in the drug
development process. To be successful and fully valued as an essential
information source, however, this document must (i) provide a comprehensive
account of the drug, (ii) have a design and structure that allows
the reader to locate quickly and easily the information needed, (iii)
have text, tables and figures that are highly readable and unambiguous,
and (iv) be up-dated whenever necessary as clinical research progresses,
to take into account new data. |
|
